These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38047034)

  • 41. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
    Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
    Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long Noncoding RNA LINC01006 Facilitates Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma via Targeting the MicroRNA 129-2-3p/CTNNB1 Axis and Activating Wnt/β-Catenin Signaling Pathway.
    Zhang Y; Liu H; Zhang Q; Zhang Z
    Mol Cell Biol; 2021 May; 41(6):e0038020. PubMed ID: 33753463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma.
    Ye W; Huang Y; Li X
    Medicine (Baltimore); 2022 Oct; 101(40):e30446. PubMed ID: 36221373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
    Wang W; Bo H; Liang Y; Li G
    Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma.
    Ying J; Hong H; Yu C; Jiang M; Ding D
    Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890.
    Kang B; Qiu C; Zhang Y
    J Healthc Eng; 2021; 2021():1643788. PubMed ID: 34306585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis.
    Gao C; Kong N; Zhang F; Zhou L; Xu M; Wu L
    BMC Bioinformatics; 2022 Aug; 23(1):327. PubMed ID: 35941550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
    Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
    Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
    Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
    Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 55. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
    Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F
    Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
    Wu Q; Jiang J
    Mol Biotechnol; 2022 Sep; 64(9):970-983. PubMed ID: 35275356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma.
    Zhou S; Cai Y; Xu Z; Peng B; Liang Q; Peng J; Yan Y
    Front Endocrinol (Lausanne); 2022; 13():964362. PubMed ID: 36034461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
    Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
    Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.